Sign in

CIK 0001689375

  • Accelerated filer
  • Smaller reporting company
  • Emerging growth company

Entrada Therapeutics, Inc.

Sign in to watch
Ticker
TRDA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
813983399
Phone
+1 857-305-1825
Business address
ONE DESIGN CENTER PLACE, SUITE 17-500, BOSTON, MA, 02210
Former names
CycloPorters, Inc.
  1. 4 Open-market sale Chief Financial Officer sold 600 shares at an average $13.02 ($7,814)
  2. 4 Open-market sale President and CEO sold 2,000 shares at $12.00 ($24,000)
  3. 4 Derivatives Options or other derivatives
  4. 4 Derivatives Options or other derivatives
  5. 4 Derivatives Options or other derivatives
  6. 4 Derivatives Options or other derivatives
  7. 4 Derivatives Options or other derivatives
  8. 4 Open-market sale Chief Operating Officer sold 7,714 shares at $13.00 ($100,282)
  9. 4 Open-market sale President and CEO sold 4,000 shares at $12.00 ($48,000)
  10. 4 Open-market buy 10% owner bought 40,947 shares at an average $6.37 ($260,760)
  11. 4 Derivatives Options or other derivatives
  12. 4 Derivatives Options or other derivatives
  13. 4 Derivatives Options or other derivatives
  14. 4 Derivatives Options or other derivatives
  15. 4 Derivatives Options or other derivatives
  16. 4 Derivatives Options or other derivatives
  17. 4 Open-market buy 10% owner bought 48,509 shares at an average $5.82 ($282,447)
  18. 4 Open-market buy 10% owner bought 71,944 shares at an average $5.99 ($430,701)
  19. 4 Grant or award Chief Operating Officer acquired 11,263 shares (grant or award)
  20. 4 Grant or award Chief Scientific Officer acquired 11,588 shares (grant or award)

Page 10 of 13 · 242 filings